Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Gerlinger

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
The Lancet. Oncology|March 2, 2010
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trialsNicolai Juul, Zoltan Szallasi, Aron C Eklund, et al.
ESMO Open|February 22, 2020
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised studyDavid Lau, Eleftheria Kalaitzaki, David N Church, et al.
Cancers|May 30, 2019
Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric AdenocarcinomaMichael Davidson, Louise J Barber, Andrew Woolston, et al.
Journal of the National Cancer Institute|April 24, 2020
Computational Image Analysis of T-Cell Infiltrates in Resectable Gastric Cancer: Association with Survival and Molecular SubtypesBenjamin R Challoner, Katharina von Loga, Andrew Woolston, et al.
The Journal of Pathology|February 25, 2012
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic targetMarco Gerlinger, Claudio R Santos, Bradley Spencer-Dene, et al.
Cancers|December 16, 2020
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and ChemotherapyFranciele H Knebel, Louise J Barber, Alice Newey, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2020
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancerVasileios Angelis, Zayd Tippu, Kroopa Joshi, et al.
Cancer Research|October 2, 2024
Resistance Management for Cancer: Lessons from FarmersSareh Seyedi, Valerie K Harris, Stefania E Kapsetaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patientsSenta M Walton, Marco Gerlinger, Olga de la Rosa, et al.
The Journal of Pathology|October 15, 2013
Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomasMarco Gerlinger, Sergio A Quezada, Karl S Peggs, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
The Lancet. Oncology|March 2, 2010
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trialsNicolai Juul, Zoltan Szallasi, Aron C Eklund, et al.
ESMO Open|February 22, 2020
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised studyDavid Lau, Eleftheria Kalaitzaki, David N Church, et al.
Cancers|May 30, 2019
Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric AdenocarcinomaMichael Davidson, Louise J Barber, Andrew Woolston, et al.
Journal of the National Cancer Institute|April 24, 2020
Computational Image Analysis of T-Cell Infiltrates in Resectable Gastric Cancer: Association with Survival and Molecular SubtypesBenjamin R Challoner, Katharina von Loga, Andrew Woolston, et al.
The Journal of Pathology|February 25, 2012
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic targetMarco Gerlinger, Claudio R Santos, Bradley Spencer-Dene, et al.
Cancers|December 16, 2020
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and ChemotherapyFranciele H Knebel, Louise J Barber, Alice Newey, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2020
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancerVasileios Angelis, Zayd Tippu, Kroopa Joshi, et al.
Cancer Research|October 2, 2024
Resistance Management for Cancer: Lessons from FarmersSareh Seyedi, Valerie K Harris, Stefania E Kapsetaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patientsSenta M Walton, Marco Gerlinger, Olga de la Rosa, et al.
The Journal of Pathology|October 15, 2013
Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomasMarco Gerlinger, Sergio A Quezada, Karl S Peggs, et al.
Pageof 7